Sandy Spring Bank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Sandy Spring Bank's DGX Position: Q1 2025 in Review
Sandy Spring Bank reduced its Quest Diagnostics (DGX) stake by 5.2% in Q1 2025, selling an estimated $4.11K and leaving 460 shares worth $77.8K. The position accounts for ﹤0.01% of the portfolio, ranked #492.
Sandy Spring Bank first reported a position in DGX in Q2 2015 and has held it in 26 quarters since. 968 funds tracked by Wall St. Rank hold DGX as of Q1 2025.
- Sandy Spring Bank held 460 shares of Quest Diagnostics worth $77.8K as of Q1 2025.
- Sandy Spring Bank sold 25 Quest Diagnostics shares in Q1 2025, an estimated $4.11K.
- Quest Diagnostics made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #492 holding.
- Sandy Spring Bank first reported a position in Quest Diagnostics in Q2 2015 and has held it in 26 quarters since.
- 968 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.